TTM
$37.2B
YoY change
+9.9%
5Y CAGR
+7.6%
Peak year (FY2025)
$36.7B
Cumulative revenue
$506B
Revenue history chart for Amgen (AMGN) from 2016 to 2025
Latest: $36.7B
Revenue growth chart for Amgen (AMGN) from 2016 to 2025
Latest: +9.9%
Revenue history table for Amgen (AMGN) from 1985 to 2025
| FY2025 | $36.7B | +9.9% | +$3.32B | ||
| FY2024 | $33.4B | +18.6% | +$5.23B | ||
| FY2023 | $28.2B | +7.1% | +$1.87B | ||
| FY2022 | $26.3B | +1.3% | +$344M | ||
| FY2021 | $26B | +2.2% | +$555M | ||
| FY2020 | $25.4B | +8.8% | +$2.06B | ||
| FY2019 | $23.4B | -1.6% | -$385M | ||
| FY2018 | $23.7B | +3.9% | +$898M | ||
| FY2017 | $22.8B | -0.6% | -$142M | ||
| FY2016 | $23B | +6.1% | +$1.33B | ||
| FY2015 | $21.7B | +8.0% | +$1.6B | ||
| FY2014 | $20.1B | +7.4% | +$1.39B | ||
| FY2013 | $18.7B | +8.2% | +$1.41B | ||
| FY2012 | $17.3B | +10.8% | +$1.68B | ||
| FY2011 | $15.6B | +3.5% | +$529M | ||
| FY2010 | $15.1B | +2.8% | +$411M | ||
| FY2009 | $14.6B | -2.4% | -$361M | ||
| FY2008 | $15B | +1.6% | +$232M | ||
| FY2007 | $14.8B | +3.5% | +$503M | ||
| FY2006 | $14.3B | +14.8% | +$1.84B | ||
| FY2005 | $12.4B | +17.8% | +$1.88B | ||
| FY2004 | $10.6B | +26.3% | +$2.19B | ||
| FY2003 | $8.36B | +51.3% | +$2.83B | ||
| FY2002 | $5.52B | +37.5% | +$1.51B | ||
| FY2001 | $4.02B | +16.5% | +$567M | ||
| FY2000 | $3.45B | +7.6% | +$244M | ||
| FY1999 | $3.2B | +21.3% | +$562M | ||
| FY1998 | $2.64B | +12.6% | +$297M | ||
| FY1997 | $2.35B | +6.7% | +$148M | ||
| FY1996 | $2.2B | +15.5% | +$294M | ||
| FY1995 | $1.9B | +17.5% | +$284M | ||
| FY1994 | $1.62B | +19.6% | +$265M | ||
| FY1993 | $1.35B | +25.4% | +$275M | ||
| FY1992 | $1.08B | +58.9% | +$401M | ||
| FY1991 | $680M | +257.0% | +$489M | ||
| FY1990 | $190M | — | — | ||
| FY1988 | $70.2M | +58.5% | +$25.9M | ||
| FY1987 | $44.3M | +48.7% | +$14.5M | ||
| FY1986 | $29.8M | +41.2% | +$8.7M | ||
| FY1985 | $21.1M | — | — |
- FY2025$36.7B+9.9%
- FY2024$33.4B+18.6%
- FY2023$28.2B+7.1%
- FY2022$26.3B+1.3%
- FY2021$26B+2.2%
- FY2020$25.4B+8.8%
- FY2019$23.4B-1.6%
- FY2018$23.7B+3.9%
- FY2017$22.8B-0.6%
- FY2016$23B+6.1%
- FY2015$21.7B+8.0%
- FY2014$20.1B+7.4%
- FY2013$18.7B+8.2%
- FY2012$17.3B+10.8%
- FY2011$15.6B+3.5%
- FY2010$15.1B+2.8%
- FY2009$14.6B-2.4%
- FY2008$15B+1.6%
- FY2007$14.8B+3.5%
- FY2006$14.3B+14.8%
- FY2005$12.4B+17.8%
- FY2004$10.6B+26.3%
- FY2003$8.36B+51.3%
- FY2002$5.52B+37.5%
- FY2001$4.02B+16.5%
- FY2000$3.45B+7.6%
- FY1999$3.2B+21.3%
- FY1998$2.64B+12.6%
- FY1997$2.35B+6.7%
- FY1996$2.2B+15.5%
- FY1995$1.9B+17.5%
- FY1994$1.62B+19.6%
- FY1993$1.35B+25.4%
- FY1992$1.08B+58.9%
- FY1991$680M+257.0%
- FY1990$190M—
- FY1988$70.2M+58.5%
- FY1987$44.3M+48.7%
- FY1986$29.8M+41.2%
- FY1985$21.1M—
Revenue values are taken from Amgen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current revenue (TTM) is $37.2B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Amgen (AMGN) most recent annual revenue stands at $36.7B (2025) – grew 9.9% year-over-year.
Across 2020–2025 (5 years), Amgen revenue produced a CAGR of +7.6% – sustaining 6 straight years of year-over-year growth.
Across the available history, revenue reached its high of $36.7B in 2025 and its low of $21.1M in 1985.
Amgen Revenue by Year
Amgen Revenue 2025: $36.7B
In 2025, Amgen reported revenue of $36.7B, grew 9.9% from 2024. This figure represents the highest annual value in the available history.
Amgen Revenue 2024: $33.4B
Amgen revenue in 2024 was $33.4B, grew 18.6% from 2023.
Amgen Revenue 2023: $28.2B
2023's revenue for Amgen came in at $28.2B, grew 7.1% from 2022.
Amgen Revenue 2022: $26.3B
Amgen posted revenue of $26.3B in 2022, edged up 1.3% from 2021.
Amgen Revenue 2021: $26B
Amgen revenue in 2021 was $26B.
See more financial history for Amgen (AMGN).
Sector peers by Revenue
Healthcare peers of Amgen (AMGN), ranked by their latest revenue
| $448B | |
| $94.2B | |
| $65.2B | |
| $64.9B | |
| $61.2B | |
| $48.2B | |
| $44.6B | |
| $44.3B |
- $94.2B
- $65.2B
- $64.9B
- $61.2B
- $48.2B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile2.53% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.